Published on 4/27/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.
New Issue: Evotec prices €18.56 million private placement of stock
By Sheri Kasprzak
New York, April 27 - Evotec AG said it has priced its previously announced private placement for €18,561,888.
The company plans to sell 5,228,701 shares at €3.55 each to institutional investors in the United States and Europe.
DZ Bank AG is the bookrunner.
Based in Hamburg, Germany, Evotec is a pharmaceutical company focused on treatments for Alzheimer's disease, sleep disorders and other ailments.
| Issuer: | Evotec AG
|
| Issue: | Stock
|
| Amount: | €18,561,888
|
| Shares: | 5,228,701
|
| Price: | €3.55
|
| Warrants: | No
|
| Placement agent: | DZ Bank AG
|
| Pricing date: | April 27
|
| Stock symbol: | Frankfurt: EVT
|
| Stock price: | €3.73 at close April 26
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
